Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Treatment of diabetes mellitus
R. P. Robertson, D. J. Klein
Medicine - Endocrine and Diabetes Division
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of diabetes mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Diabetes Mellitus Treatment
100%
Chronic Diabetic Complications
100%
Disease Progression
50%
Type I Diabetes
50%
Type 1 Diabetes Mellitus (T1DM)
50%
Type 2 Diabetes Mellitus (T2DM)
50%
Insulin Resistance
50%
Insulin
50%
Islet Transplantation
50%
Pancreas
50%
Insulin Secretion
50%
Cyclosporine
50%
Diabetic Nephropathy
50%
Hypertension
50%
Insulin Independence
50%
Insulin Therapy
50%
Hypertension Management
50%
Genetic Markers
50%
Physiologic
50%
Biochemical Markers
50%
Nephropathy
50%
Immunogenetics
50%
β-cell Mass
50%
Cellular Level
50%
Long-term Remission
50%
Glycogen Synthesis
50%
Chronic Hyperglycemia
50%
Metabolic Consequences
50%
Insulin Deficiency
50%
Vanadate
50%
Insulin Action
50%
New Treatment Options
50%
Familial Clustering
50%
Normoglycaemia
50%
Counter-transport
50%
Sulfonylurea
50%
Alternate Strategy
50%
Muscle Glucose Uptake
50%
Renal Deterioration
50%
Moderate Hyperglycaemia
50%
Type 2 (non-insulin-dependent) Diabetes Mellitus
50%
Medicine and Dentistry
Disease
100%
Maturity Onset Diabetes of the Young
100%
Complications of Diabetes Mellitus
100%
Diabetes Mellitus
100%
Hyperglycemia
100%
Insulin Dependent Diabetes Mellitus
50%
Beta Cell
50%
Insulin Resistance
50%
Diabetic Nephropathy
50%
Disease Exacerbation
50%
Insulin Treatment
50%
Secretion (Process)
50%
Nephropathy
50%
Deterioration
50%
Cyclosporine
50%
Azathioprine
50%
Glucose Uptake
50%
Genetic Marker
50%
Biochemical Marker
50%
Insulin Deficiency
50%
Familial Disease
50%
Islet Cell Transplantation
50%
Glycogen Synthesis
50%
Immunogenetics
50%
Immunotherapy
50%
Sulfonylurea
50%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Diabetic Complication
100%
Disease
100%
Diabetes Mellitus
100%
Hyperglycemia
100%
Sulfonylurea
50%
Insulin Dependent Diabetes Mellitus
50%
Disease Exacerbation
50%
Ciclosporin
50%
Remission
50%
Azathioprine
50%
Kidney Disease
50%
Deterioration
50%
Insulin Deficiency
50%
Familial Disease
50%
Insulin Resistance
50%
Immunotherapy
50%
Diabetic Nephropathy
50%
Immunology and Microbiology
Genetic Marker
100%
Cell Transplantation
100%
Ciclosporin
100%
Secretion (Process)
100%
Pancreas
100%
Immunogenetics
100%
Glucose Blood Level
100%
Azathioprine
100%
Glycogen Synthesis
100%
Glucose Transport
100%
Immunotherapy
100%